Communication and Teamwork
Information that actually lands
Communication in trials is a planned, documented activity rather than a courtesy. A communication plan maps stakeholders - participants, site staff, monitors, sponsor functions, vendors, regulators, IRB/IEC - to what they need, when, through which channel, and who owns delivery. Cross-functional teams (clinical operations, data management, safety, regulatory, biostatistics, and the site) fail most often at the seams, so exam scenarios usually hinge on an unclear owner or an undocumented verbal instruction.
Escalation should be defined in advance: what triggers it (a serious adverse event, a protocol deviation, an enrollment shortfall, a data breach), who must be told, and how quickly. Safety information carries the shortest clock and does not wait for a weekly meeting. Written follow-up after calls and meetings converts intent into a record.
Participant communication is a distinct skill. Consent discussions and participant materials should use plain language at an appropriate reading level, be culturally appropriate, and be available in the participant's language with qualified translation and back-translation. Teach-back - asking the participant to explain the study in their own words - confirms comprehension in a way that "do you have any questions?" does not.
Trap: a scenario where everyone "agreed in a meeting" but nobody documented the decision, or where a well-meaning coordinator gives clinical advice instead of routing the question to the investigator.
Rule of thumb: name the owner and the due date in every action item. Worked example: a Spanish-speaking participant's consent form is translated informally by a bilingual coordinator without back-translation. Correct practice is certified forward translation and independent back-translation, IRB approval of the translated document, and a consent discussion with a qualified interpreter - not a summary conversation.